VP, B., CL, H., D, Q., J, S., J, P., & T, P. (2025). Thienopyrimidine amide analogs target MmpL3 in Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 69(11), e0098025. https://doi.org/10.1128/aac.00980-25
Chicago Style (17th ed.) CitationVP, Baldin, Harding CL, Quach D, Sugie J, Pogliano J, and Parish T. "Thienopyrimidine Amide Analogs Target MmpL3 in Mycobacterium Tuberculosis." Antimicrobial Agents and Chemotherapy 69, no. 11 (2025): e0098025. https://doi.org/10.1128/aac.00980-25.
MLA (9th ed.) CitationVP, Baldin, et al. "Thienopyrimidine Amide Analogs Target MmpL3 in Mycobacterium Tuberculosis." Antimicrobial Agents and Chemotherapy, vol. 69, no. 11, 2025, p. e0098025, https://doi.org/10.1128/aac.00980-25.
Warning: These citations may not always be 100% accurate.